This case demonstrated the potential clinical benefits of combining vinorelbine chemotherapy with NK cell-activating cytokines (IL-15, IL-12, IL-23, and selenium) in a dog with stage IV PAC. This evidence concerns the gene IL15 and gonorrhea.